We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Lundbeck (Ireland) Limited

4045 Kingswood Road, Citywest Business Park, Co Dublin, Ireland
Telephone: +353 01 468 9800
Fax: +44 1908 638 959
Medical Information e-mail: ukinfo@lundbeck.com
Patient Information Leaflet last updated on medicines.ie: 20/03/2017
PIL Ebixa Oral Solution

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 20/03/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 6 - date of revision
Updated on 23/12/2014 and displayed until 20/03/2017
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to date of revision
  • Change to improve clarity and readability
Updated on 21/07/2014 and displayed until 23/12/2014
Reasons for adding or updating:
  • Change to date of revision
  • Addition of marketing authorisation holder
Updated on 08/06/2012 and displayed until 21/07/2014
Reasons for adding or updating:
  • Change to side-effects
Updated on 04/11/2011 and displayed until 08/06/2012
Reasons for adding or updating:
  • Change to MA holder contact details
  • Change to product name
Updated on 10/01/2011 and displayed until 04/11/2011
Reasons for adding or updating:
  • Change of trade or active ingredient name
Updated on 17/06/2010 and displayed until 10/01/2011
Reasons for adding or updating:
  • Change to side-effects
Updated on 23/04/2010 and displayed until 17/06/2010
Reasons for adding or updating:
  • Change to dosage and administration
  • Correction of spelling/typing errors
Updated on 20/08/2009 and displayed until 23/04/2010
Reasons for adding or updating:
  • Deletion of a pack size
Updated on 31/07/2009 and displayed until 20/08/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 22/12/2008 and displayed until 31/07/2009
Reasons for adding or updating:
  • Change to side-effects
Updated on 09/06/2008 and displayed until 22/12/2008
Reasons for adding or updating:
  • Change to dosage and administration
  • Change to marketing authorisation holder address
Updated on 24/09/2007 and displayed until 09/06/2008
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 03/08/2007 and displayed until 24/09/2007
Reasons for adding or updating:
  • Change to date of revision
Updated on 05/04/2007 and displayed until 03/08/2007
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 20/12/2006 and displayed until 05/04/2007
Reasons for adding or updating:
  • Change to side-effects
Updated on 24/05/2006 and displayed until 20/12/2006
Reasons for adding or updating:
  • Change to side-effects
Updated on 13/04/2006 and displayed until 24/05/2006
Reasons for adding or updating:
  • Change to, or new use for medicine
Updated on 15/08/2005 and displayed until 13/04/2006
Reasons for adding or updating:
  • Improved electronic presentation
Updated on 14/09/2004 and displayed until 15/08/2005
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Memantine hydrochloride